The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 16, 2021
Filed:
Jul. 30, 2020
Applicant:
Molecular Rebar Design, Llc, Austin, TX (US);
Inventors:
Kurt W. Swogger, Austin, TX (US);
Gregory L. Porter, Spring, TX (US);
Milos Marinkovic, Austin, TX (US);
Assignee:
Molecular Rebar Design, LLC, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01D 46/00 (2006.01); B01J 20/20 (2006.01); B01J 20/26 (2006.01); B01J 20/24 (2006.01); B01J 20/10 (2006.01); B01J 20/02 (2006.01); B01J 20/28 (2006.01); A61L 9/014 (2006.01); B01D 39/20 (2006.01); B01D 39/16 (2006.01); A61L 101/26 (2006.01);
U.S. Cl.
CPC ...
B01J 20/205 (2013.01); A61L 9/014 (2013.01); B01D 39/1623 (2013.01); B01D 39/2065 (2013.01); B01D 46/0028 (2013.01); B01D 46/0036 (2013.01); B01J 20/0233 (2013.01); B01J 20/0237 (2013.01); B01J 20/103 (2013.01); B01J 20/24 (2013.01); B01J 20/261 (2013.01); B01J 20/262 (2013.01); B01J 20/267 (2013.01); B01J 20/28038 (2013.01); A61L 2101/26 (2020.08); A61L 2209/14 (2013.01); B01D 2239/025 (2013.01); B01D 2239/0414 (2013.01); B01D 2239/0442 (2013.01); B01D 2257/91 (2013.01); B01D 2279/65 (2013.01);
Abstract
Nanotube compositions may be employed in many different forms alone, and/or with surfactants, with antiviral metals, with antigens, and/or with various drugs to control pathogens like viruses e.g., SARS COVID-2, bacteria, mold, fungi, chemical or biological agents etc in masks or other personal protection equipment. The personal protection equipment such as masks reduce, control, absorb, deactivate, detoxify, and/or kill the pathogens such that a pathogen or pathogens deleterious effects are reduced and/or eliminated to a user of the mask.